Pharmaceutical

STAT+: Medicare announces loan program to aid providers...

Medicare will make advance payments to physician groups, hospitals, and other fa...

STAT+: Eli Lilly’s anti-vanity ad campaign for Oscars

Eli Lilly will be unveiling a new campaign during this weekend’s Oscar awards ev...

What’s next for AAV gene therapies in 2024?

Upcoming regulatory events for pipeline AAV gene therapies, with a focus on neur...

Opinion: STAT readers on new CDC Covid guidelines, weig...

In letters to the editor, high-risk people express concern about the CDC’s new C...

AD/PD 2024: TauRx’s HMTM promising despite lacking prim...

Participants cannot remain blind to their treatment arm due to the properties of...

AD/PD 2024: exploring cutting-edge therapies for ALS

While some biotechs are attempting to develop disease-modifying therapies for am...

FDA delays action on Lilly’s donanemab, intent on advis...

While Lilly’s Alzheimer’s drug was previously expected in Q1 2024, an FDA-mandat...

BeiGene secures accelerated FDA approval for follicular...

The FDA has already granted accelerated approvals to several third-line treatmen...

AD/PD 2024: Vaxxinity reveals Phase I success with Park...

The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease...

Amylyx considers scrapping ALS drug following Phase III...

Amylyx’s stocks plummeted by more than 85% after announcing it is considering sc...

Oligonucleotides: Overcoming sustainability challenges ...

CPI’s new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotl...

SK bioscience to expand vaccine manufacturing plant in ...

SK bioscience has broken ground on a significant expansion of its vaccine manufa...

Johnson & Johnson acquires Ambrx Biopharma for $2bn

Johnson & Johnson (J&J) has concluded the acquisition of Ambrx Biopharma in a tr...

FDA approves BMS’ Opdivo for urothelial carcinoma

The US FDA has granted approval for BMS' Opdivo for the first-line treatment of ...

RSV monoclonal Beyfortus was 90% effective at preventin...

Beyfortus, a new shot for RSV, was 90% effective at preventing hospitalizations ...

STAT+: Pharmalittle: We’re reading about a Lilly obesit...

Ahead of the Oscars and amid shortages, Lilly is running a new ad campaign urgin...